Hygeia Healthcare Holdings Management

Management criteria checks 4/4

Hygeia Healthcare Holdings' CEO is Yiwen Zhu, appointed in Aug 2021, has a tenure of 3.25 years. total yearly compensation is CN¥2.49M, comprised of 24.1% salary and 75.9% bonuses, including company stock and options. directly owns 44.98% of the company’s shares, worth HK$4.60B. The average tenure of the management team and the board of directors is 3.8 years and 5 years respectively.

Key information

Yiwen Zhu

Chief executive officer

CN¥2.5m

Total compensation

CEO salary percentage	24.1%
CEO tenure	3.3yrs
CEO ownership	45.0%
Management average tenure	3.8yrs
Board average tenure	5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Yiwen Zhu's remuneration changed compared to Hygeia Healthcare Holdings's earnings?
Date	Total Compensation	Salary	Company Earnings
Jun 30 2024	n/a	n/a	CN¥733m
Mar 31 2024	n/a	n/a	CN¥708m
Dec 31 2023	CN¥2m	CN¥600k	CN¥683m
Sep 30 2023	n/a	n/a	CN¥635m
Jun 30 2023	n/a	n/a	CN¥587m
Mar 31 2023	n/a	n/a	CN¥532m
Dec 31 2022	CN¥4m	CN¥492k	CN¥477m
Sep 30 2022	n/a	n/a	CN¥472m
Jun 30 2022	n/a	n/a	CN¥468m
Mar 31 2022	n/a	n/a	CN¥455m
Dec 31 2021	CN¥709k	CN¥239k	CN¥441m
Sep 30 2021	n/a	n/a	CN¥403m
Jun 30 2021	n/a	n/a	CN¥365m
Mar 31 2021	n/a	n/a	CN¥268m
Dec 31 2020	CN¥45k	CN¥37k	CN¥170m
Sep 30 2020	n/a	n/a	CN¥100m
Jun 30 2020	n/a	n/a	CN¥29m
Mar 31 2020	n/a	n/a	CN¥35m
Dec 31 2019	CN¥779k	CN¥684k	CN¥40m

Compensation vs Market: Yiwen's total compensation ($USD344.08K) is about average for companies of similar size in the Hong Kong market ($USD487.48K).

Compensation vs Earnings: Yiwen's compensation has been consistent with company performance over the past year.

CEO

Yiwen Zhu (60 yo)

3.3yrs

Tenure

CN¥2,493,000

Compensation

Mr. Yiwen Zhu serves as Executive Director & Co-Chief Executive Officer of at Hygeia Healthcare Holdings Co., Limited since August 23, 2021. He serves as Chairman of the Board at Hygeia Healthcare Holdings...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Yiwen Zhu	Chairman & Co-CEO	3.3yrs	CN¥2.49m	44.98% HK$ 4.6b
Huanhuan Cheng	Co-CEO & Executive Director	3.3yrs	CN¥1.54m	no data
Wenshan Zhang	Director of Research & Development	4.8yrs	CN¥1.51m	0.0052% HK$ 528.4k
Hui Jiang	Director of Radiotherapy Division & Executive Director	3.9yrs	CN¥1.33m	no data
Ai Ren	Joint Company Secretary	no data	CN¥2.32m	0.46% HK$ 46.8m
Xue Yu	Financial Director	no data	no data	no data
Kwok Yin Lau	Joint Company Secretary	3.8yrs	no data	no data

3.8yrs

Average Tenure

42yo

Average Age

Experienced Management: 6078's management team is considered experienced (3.8 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Yiwen Zhu	Chairman & Co-CEO	3.7yrs	CN¥2.49m	44.98% HK$ 4.6b
Huanhuan Cheng	Co-CEO & Executive Director	5.4yrs	CN¥1.54m	no data
Wenshan Zhang	Director of Research & Development	4.8yrs	CN¥1.51m	0.0052% HK$ 528.4k
Hui Jiang	Director of Radiotherapy Division & Executive Director	3.9yrs	CN¥1.33m	no data
Ai Ren	Joint Company Secretary	6.2yrs	CN¥2.32m	0.46% HK$ 46.8m
Changqing Ye	Independent Non-Executive Director	5.2yrs	CN¥240.00k	no data
Chun Zhao	Independent Non-Executive Director	2.5yrs	CN¥240.00k	no data
Yanqun Liu	Independent Non-Executive Director	5.2yrs	CN¥240.00k	no data

5.0yrs

Average Tenure

51yo

Average Age

Experienced Board: 6078's board of directors are considered experienced (5 years average tenure).

Hygeia Healthcare Holdings Management

Management criteria checks 4/4

Key information

Recent management updates

Chairman & Co-CEO recently bought HK$13m worth of stock

Hygeia Healthcare Holdings Co., Limited, Annual General Meeting, Jun 28, 2024

Chairman & Co-CEO recently bought HK$4.1m worth of stock

Chairman & Co-CEO recently bought HK$20m worth of stock

Chairman & Co-CEO recently bought HK$9.0m worth of stock

Hygeia Healthcare Holdings Co., Limited Announces Chief Financial Officer Changes

Recent updates

Investor sentiment improves as stock rises 34%

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 21%

First half 2024 earnings released: EPS: CN¥0.61 (vs CN¥0.53 in 1H 2023)

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2024 Results on Aug 29, 2024

Full year 2023 earnings released: EPS: CN¥1.08 (vs CN¥0.77 in FY 2022)

Chairman & Co-CEO recently bought HK$13m worth of stock

Investor sentiment improves as stock rises 21%

Hygeia Healthcare Holdings Co., Limited, Annual General Meeting, Jun 28, 2024

Full year 2023 earnings released: EPS: CN¥1.08 (vs CN¥0.77 in FY 2022)

Hygeia Healthcare Holdings Co., Limited to Report Fiscal Year 2023 Results on Mar 26, 2024

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 16%

Chairman & Co-CEO recently bought HK$4.1m worth of stock

Chairman & Co-CEO recently bought HK$20m worth of stock

Investor sentiment deteriorates as stock falls 24%

Chairman & Co-CEO recently bought HK$9.0m worth of stock

First half 2023 earnings released: EPS: CN¥0.53 (vs CN¥0.36 in 1H 2022)

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2023 Results on Aug 29, 2023

Hygeia Healthcare Holdings Co., Limited (SEHK:6078) entered into the acquisition agreement to acquire Datang International (Hong Kong) Limited for CNY 1.2 billion.

Now 22% undervalued after recent price drop

Upcoming dividend of CN¥0.15 per share at 0.4% yield

Full year 2022 earnings released: EPS: CN¥0.77 (vs CN¥0.71 in FY 2021)

Hygeia Healthcare Holdings Co., Limited has completed a Follow-on Equity Offering in the amount of HKD 791.8 million.

Hygeia Healthcare Holdings Co., Limited Announces Chief Financial Officer Changes

Now 22% undervalued after recent price drop

Less than half of directors are independent

Now 22% undervalued after recent price drop

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Hygeia Healthcare Holdings Co., Limited (SEHK:6078) acquired 30% of KAIYUAN JIEHUA HOSPITAL CO., LTD for CNY 15.3 million.

First half 2022 earnings released: EPS: CN¥0.36 (vs CN¥0.32 in 1H 2021)

Hygeia Healthcare Holdings Co., Limited Omits Dividend for the Six Months Ended June 30, 2022

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2022 Results on Aug 31, 2022

Investor sentiment improved over the past week

Hygeia Healthcare Holdings Co., Limited Announces Management Changes

Full year 2021 earnings released: EPS: CN¥0.71 (vs CN¥0.38 in FY 2020)

Less than half of directors are independent

Full year 2021 earnings released: EPS: CN¥0.71 (vs CN¥0.38 in FY 2020)

Hygeia Healthcare Holdings Co., Limited Resolves Not to Declare Final Dividend for the Year Ended December 31, 2021

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Chairman & Co-CEO recently bought HK$15m worth of stock

Joint Company Secretary recently bought HK$11m worth of stock

Investor sentiment deteriorated over the past week

Chairman & Co-CEO recently bought HK$4.4m worth of stock

First half 2021 earnings released: EPS CN¥0.32 (vs CN¥0.008 in 1H 2020)

First half 2021 earnings released: EPS CN¥0.32 (vs CN¥0.008 in 1H 2020)

Board Member recently sold HK$6.2m worth of stock

Director of Research & Development recently sold HK$2.7m worth of stock

Full year 2020 earnings released: EPS CN¥0.38 (vs CN¥0.14 in FY 2019)

Hygeia Healthcare Holdings Co., Limited (SEHK:6078) entered into a share purchase agreement to acquire 98% stake in Suzhou Yongding Hospital from Ascendent Capital Partners I, L.P. managed by Ascendent Capital Partners (Asia) Limited for CNY 1.7 billion.

Full year 2020 earnings released: EPS CN¥0.38 (vs CN¥0.14 in FY 2019)

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age